Scholars Central

Conference abstractPublished 23 Mar 2015

Better manufacturing practice for cell therapies

Authors: Kevin Murray

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

The Xvivo GMP platform reduces risk and provides superior process control for the culture, processing, and expansion of cell-based therapeutics. Total isolation protects the cells from possible contamination, the people from viral vectors, prions, as well as allow for the optimization of the cell environment. Critical cell environmental factors such as temperature, RH, CO2 and O2 can be controlled, monitored and uninterrupted throughout the entire cell production process. Dynamic incubation options allow for adjustments in incubation conditions which keep up with the changing needs of dynamic cell cultures. Superior process control results in a higher quality cell product and more consistent results for your entire protocol.

Subjects

Biology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

More from this journal

The newest in Journal of Cell Science & Therapy.

All its articles

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Cell Science & Therapy
  • SubjectBiology
  • BylineArticles whose byline prints “Kevin Murray”

For authors and organisers

Publish, present and keep up with your field

Find the right journal for your paper and submit your manuscript.

Photo: Pexels